Abstract. This study aimed to investigate whether oxidative stress contributes to retinal cell death in a mouse model of photoreceptor degeneration induced by N-methyl-N-nitrosourea (MNU). We measured in vitro MNU-induced radical production in retinal cell cultures of murine 661W photoreceptor-derived cells; RGC-5, a mouse ganglion cell line; and primary retinal cells. The addition of MNU induced oxidative radical generation in 661W and primary retinal cells, but not in RGC-5 cells. Edaravone, a free radical scavenger, at 1 μM reduced MNU-induced radical production in 661W and primary retinal cells. To induce in vivo retinal photoreceptor degeneration in mice, we administered 60 mg/kg MNU by intraperitoneal injection. We intravenously administered 1 mg/kg edaravone immediately and at 6 h after the MNU injection. Retinal photoreceptor degeneration was evaluated by measuring the thickness of the outer nuclear layer (ONL) by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining and by oxidative stress markers. MNU caused photoreceptor cell loss at 7 days after administration. Edaravone inhibited ONL thinning and reduced TUNEL-positive cells and the oxidative stress markers. These findings indicate that MNU leads to selective photoreceptor degradation via oxidative stress in vitro and in vivo and may help to understand the pathogenic mechanism of retinitis pigmentosa.
Introduction
Retinitis pigmentosa is a disease characterized by a loss of photoreceptor cells, especially rods, which leads to visual disturbance and, eventually, blindness. No therapeutic drugs have yet been discovered for retinitis pigmentosa; therefore, the development of new drugs for therapeutic intervention is of paramount importance. NMethyl-N-nitrosourea (MNU) is a direct-acting alkylating agent that induces retinal photoreceptor cell death by an apoptotic mechanism (1) . In a range of animals including adult mice and rats, MNU has been reported to induce photoreceptor cell death at approximately 7 days after a single systemic administration (2 -4) . The cell death is attributed to the restriction of DNA adduct formation, and photoreceptor cell nuclei show apoptosis as evidenced by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining. MNUinduced cell degeneration is accompanied by the upregulation of Bax protein, down-modulation of Bcl-2 protein, and activation of the caspase family of genes (5) . Although the apoptosis cascade may be different in humans, retinitis pigmentosa is also characterized by a loss of photoreceptor cells via an apoptotic mechanism. Since MNU-induced retinal degeneration is caused by photoreceptor cell apoptosis, it is possible that a common mechanism exists between MNU-induced photoreceptor loss and retinitis pigmentosa.
Oxidative stress can contribute to neuronal toxicity and appears to be involved in both acute injury and chronic neuropathological conditions (6) . Reactive oxygen species (ROS) production in response to oxidative stress has been implicated as a stage in the final common pathway that leads to neurotoxicity in a variety of acute and chronic neurologic eye diseases including glaucoma (7), age-related macular degeneration (8) , and retinitis pigmentosa (9) . An early and sustained increase in intracellular ROS precedes the disruption of mitochondrial transmembrane potential, nuclear condensation, DNA nicking, and cell shrinkage, all of which are well-characterized events of apoptotic photoreceptor cell death (10) . MNU enhances these free radical-mediated processes (11) , suggesting that oxidative stress may play a part in the underlying mechanism of MNU responses.
Edaravone, a free radical scavenger, has been approved for the clinical treatment of acute cerebral infarction (12) and has been shown to exert protective effects against cerebral ischemia-reperfusion injuries in a variety of experimental animal models (13 -15) . In an experimental study using cerebrocortical slice cultures from neonatal rats, edaravone was found to reduce N-methyl-Daspartate (NMDA)-induced cytochrome c release and apoptosis (16) . Edaravone has been shown to inhibit 1) the accumulation of oxidative by-products, such as 4-hydroxy-2-nonenal (4-HNE) and 8-hydroxy-deoxyguanosine (8-OHdG) and 2) neuronal cell death in mice after transient focal cerebral ischemia (17) . These protective effects of edaravone are thought to be attributed to its ROS scavenging ability. We reported that systemic administration of edaravone could attenuate NMDAinduced retinal damage (18) . Therefore, the present study aimed to clarify the involvement of oxidative stress in MNU-induced retinal photoreceptor damage and evaluate the protective effects of edaravone against MNU-induced retinal cell damage.
Materials and Methods

Materials
MNU was purchased from Sigma-Aldrich (St. Louis, MO, USA); edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), from Wako (Osaka); and isoflurane, from Nissan Kagaku (Tokyo).
Animals
Male adult ddY mice (Japan SLC, Hamamatsu) were maintained under controlled lighting conditions (12 h : 12 h light/dark cycle). The ddY mice are an outbred albino strain and have been maintained as a closed colony. This strain has been widely used in trials for drug efficacy and various fields of research, including pharmacological, phamacokinetic, and toxicological studies. All experiments were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved and monitored by the Institutional Animal Care and Use Committee of Gifu Pharmaceutical University.
661W photoreceptor cells and RGC-5 cultures
The 661W cell line was derived from mouse retinal tumors and has been previously characterized and shown to be of the cone photoreceptor cell lineage (19) . RGC-5 is a mouse ganglion cell line (20, 21) . 661W and RGC-5 cells were maintained in Dulbecco's modified Eagle's medium (DMEM, Sigma-Aldrich) containing 10% fetal bovine serum (FBS), 100 U/mL penicillin (Meiji Seika Kaisha, Ltd., Tokyo), and 100 μg/mL streptomycin (Meiji Seika Kaisha) under a humidified atmosphere of 95% air and 5% CO 2 at 37°C. The cells were passaged by trypsinization every 3 to 4 days.
Primary retinal culture
Retinas from P8 mice were dissected free of choroidal vessels and dissociated by activated papain for 15 min at 37°C, using the protocol of Yi et al. (22) . Neurobasal medium (Invitrogen, Carlsbad, CA, USA) containing ovomucoid (Sigma-Aldrich) plus DNase (Invitrogen) was added, and the cells were centrifuged at 100 × g for 8 min at room temperature. The cell pellet was resuspended in neurobasal-Ovo medium without DNase, recentrifuged, and resuspended in neurobasal medium containing L-glutamine, B27 (Invitrogen), and antibiotics. Cells were plated onto poly-D-lysine/laminin-coated 96-well dishes at 2.5 × 10 5 cells/well.
In vitro immunostaining
The primary retinal cultures were plated onto glass chamber slides (Laboratory-Tek; Life Technologies, Gaithersburg, MD, USA), fixed with 4% fresh paraformaldehyde at room temperature, blocked in 3% goat serum and 0.2% Triton X-100 in PBS, and incubated overnight at 4°C with primary antibodies [mouse anti-rhodopsin (clone 4D2; Millipore, Bedford, MA, USA) and mouse anti-glial fibrillary acidic protein (GFAP) monoclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA)] diluted in PBS. After being washed, the cells were incubated for 1 h with secondary antibodies (Alexa Fluor ® 488 goat anti-mouse IgG and Alexa Fluor ® 546 rabbit anti-mouse IgG, both from Invitrogen), washed, and counterstained with Hoechst 33342 (Invitrogen); images were captured using a BZ-9000 Biorevo all-inone fluorescence microscope (Keyence, Osaka). MNU was added at 100 μg/mL to the cultures. The total number of cells was determined in a blind manner (by M.Y.), and the percentages of rhodopsin-and GFAP-positive cells were calculated.
Cell viability
To evaluate cell survival, we examined the change in the fluorescence intensity after the cellular reduction of WST-8 to formazan. The experiment was performed in neurobasal medium containing B27 minus antioxidant at 37°C. Primary retinal cells were plated onto poly-Dlysine/laminin-coated 96-well dishes at 2.5 × 10 5 cells/ well. Cells were washed with neurobasal medium containing B27 minus antioxidant. MNU was added at 10, 100, and 1000 μg/mL, and the cells were incubated for 12 h. Cell viability was assessed by culturing the cells in a culture medium containing 10% WST-8 (Cell Counting Kit-8; Dojin Kagaku, Kumamoto) for 3 h at 37°C and then by scanning with a microplate reader (Varioskan Flash 2.4; Thermo Fisher Scientific, Waltham, MA, USA) at 492 nm. Absorbance was expressed as the percentage of the absorbance in control cells (cultured in Neurobasal medium containing B27 minus antioxidant) after subtracting background absorbance.
Radical-scavenging capacity assay
This assay measures the radicals induced by MNU in retinal cells. 661W and RGC-5 cells were seeded at a density of 2 × 10 3 cells/well into 96-well plates and then incubated in a humidified atmosphere of 95% air and 5% CO 2 at 37°C for 24 h. Cells were washed with 1% FBS-DMEM. After a 1-h pretreatment with edaravone or vehicle (PBS), 10 μM of 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H 2 DCFDA, Invitrogen), the radical probe, was added to the cell culture and incubation was continued for an additional 20 min at 37°C; the cell culture medium was then replaced to remove any excess probe. The radical probe was converted to 2′,7′-dichlorodihydrofluorescein (DCFH, active for ROS) by the action of intracellular esterase. Intracellular DCFH (nonfluorescent) was oxidized to 2′,7′-dichlorfluorescein (DCF, fluorescent) by intracellular ROS. Then, MNU at 1 -1000 μg/mL or H 2 O 2 at 1 mM was added. H 2 O 2 was treated as a positive control. Fluorescence was measured after H 2 O 2 or MNU had been present for various time periods, using a Varioskan Flash 2.4 microplate reader (Thermo Fisher Scientific) at the excitation/emission wavelengths of 485/535 nm.
Primary retinal cells were seeded at 2.5 × 10 5 cells/ well into 96-well plates. Cells were washed with neurobasal medium containing B27 minus antioxidant. Then, a radical assay was performed following the same protocol as described above.
Radical integrals were calculated by integrating the area under the CM-H 2 DCFDA fluorescence intensity curve after a 20-min treatment with ROS-generating compounds.
To detect the cell types that generate ROS in primary cells, we used fluorescence microscopy to analyze the cellular radicals induced by MNU. Primary retinal cells were seeded at 2.5 × 10 5 cells/well into 96-well plates.
Cells were washed with neurobasal medium containing B27 minus antioxidant. After a 1-h pretreatment with edaravone or vehicle, 100 μg/mL MNU, CM-H 2 DCFDA, and Hoechst 33342 were added, and the cells were further incubated for 20 min. Images were collected using an Olympus CCD camera and microscope (IX-70; Olympus, Tokyo). The total number of cells was determined in a blind manner (by M.Y.), and the percent of cells exhibiting DCF fluorescence was calculated.
MNU-induced retinal damage
MNU-induced retinal damage in mice was induced by an i.p. injection of 60 mg/kg MNU dissolved in saline, as previously reported by Smith et al. (23) . Edaravone (0.1 or 1 mg/kg) or vehicle (saline) was i.v. injected immediately and at 6 h after the injection of MNU. At 7 days after the injection, the eyeballs were enucleated for histological analysis.
Histological analysis
The mice were killed by an i.p. injection of a lethal dose of sodium pentobarbital (80 mg/kg), and each eye was enucleated. The eyes were kept immersed in a fixative solution containing 4% paraformaldehyde for at least 24 h at 4°C. Six paraffin-embedded sections (4-μm-thick) were cut parallel with the maximum circumference of the eyeball through the optic disc (as we extracted the eyeball, we identified the dorsal-most point by using the landmark of the optic axis). These sections were then stained with hematoxylin and eosin. The damage induced by MNU at 45, 60, and 75 mg/kg was evaluated by morphometric analysis of each eye. Light microscopic images were captured using a digital camera (CoolPix 4500; Nikon, Tokyo). The vertical lengths of the inner nuclear layer (INL) and outer nuclear layer (ONL) at a distance between 375 and 625 μm from the optic disc (nasal and temporal portions) were measured on the photomicrographs in a blinded manner by a single observer (Y.I.) and averaged to obtain a single value. The data were averaged for each eye.
TUNEL staining
TUNEL staining was performed according to the manufacturer's protocols (In Situ Cell Death Detection Kit; Roche Biochemicals, Mannheim, Germany) to detect retinal cell death induced by MNU. The mice were killed by an i.p. injection of a lethal dose of pentobarbital sodium (80 mg/kg) at 12, 24, 36, 48, and 72 h after i.p. injection of 60 mg/kg MNU. The eyes were enucleated, fixed overnight in 4% paraformaldehyde, and immersed in 25% sucrose in PBS for 48 h at 4°C. The eyes were then embedded in a supporting medium for frozen tissue specimens (optimal cutting temperature compound, Tissue-Tek; Miles Laboratories, Naperville, IL, USA). Retinal sections of 10-μm thickness were cut at −25°C using a cryostat and stored at −80°C until staining. After being washed with PBS twice, the sections were incubated with fluorescein-labeled terminal deoxyribonucleotidyl transferase enzyme at 37°C for 1 h. The sections were washed 3 times in PBS at room temperature, each for 1 min, and then developed. Fluorescent microscopic images were acquired, and labeled cells in the ONL at a distance between 375 and 625 μm from the optic disc were obtained in 2 areas of the retina.
Fluorescein-labeled TUNEL-positive retinal cell density in the ONL at a distance between 475 and 525 μm (50 × 50 μm) from the optic disc was evaluated by appropriately calibrated computerized image analysis, using Image J (Image Processing and Analysis in Java; National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA). The density of TUNELpositive cells in the ONL and the median volume were determined as an average of 2 areas.
In vivo immunostaining
The eyes were enucleated as described in the " Histological analysis" section, fixed in 4% paraformaldehyde overnight at 4°C, immersed in 25% sucrose for 48 h at 4°C, and embedded in optimal cutting temperature compound (Sakura Finetechnical Co., Ltd., Tokyo). Transverse cryostat sections of 10-μm thickness were cut and placed onto slides (MAS COAT; Matsunami Glass Ind., Ltd., Osaka). These tissue sections were washed in 0.01 mM PBS for 10 min, and then endogenous peroxidase was quenched by treating the sections with 3% hydrogen peroxide in absolute methanol for 10 min, followed by a pre-incubation with 10% normal goat serum. The primary antibodies used were 8-OHdG and 4-HNE mouse monoclonal antibodies (both from the Japan Institute for the Control of Aging, Shizuoka). These primary antibodies were diluted in PBS (1:1000) and then incubated with the tissue sections overnight at 4°C. The sections were washed and then incubated with biotinylated anti-rabbit IgG or anti-mouse IgG. They were subsequently incubated with the avidin-biotin-peroxidase complex for 30 min and then developed using diaminobenzidine (DAB) peroxidase as substrate for 1 min. We confirmed the staining by comparison with a negative control (not treated with the first antibody). Images were obtained using a digital camera (CoolPix 4500).
8-OHdG-and 4-HNE-positive cell expression
To investigate 8-OHdG-positive cells, we evaluated the samples of DAB-labeled cells (for anti-8-OHdG) in the ONL at a distance between 375 and 625 μm from the optic disc. Retinal DAB-labeled cells were counted and averaged for 2 areas.
To investigate 4-HNE-positive cells, we evaluated samples in the DAB-labeled area (for anti-4-HNE) in photoreceptors at a distance between 475 and 525 μm (50 × 50 μm) from the optic disc. DAB-labeled retinal cell density, evaluated by appropriately calibrated computerized image analysis using Image J, and the median volume of the pixels in the image or selection were averaged for each area. Briefly, light micrographs of the measured areas were inverted in a gradation sequence using Adobe Photoshop 5.5 (Adobe Systems, San Jose, CA, USA). The optical intensity was then evaluated using Image J. From the obtained score, we subtracted the score obtained for the negative control (not treated with the first antibody) as the background value.
Statistical analysis
Data are presented as the mean ± S.E.M. Statistical comparisons were made using a one-way ANOVA followed by a Dunnett's test or Student's t-test (using STAT VIEW version 5.0; SAS Institute, Cary, NC, USA). A P-value of < 0.05 was considered to indicate statistical significance. A P-value of < 0.01 was described as highly significant.
Results
Intracellular oxidation of DCFH induced by MNU in 661W and RGC-5 cells
To investigate whether MNU induces radical production, we measured the intracellular ROS levels using the ROS-sensitive probe CM-H 2 DCFDA. The kinetics of ROS reactivity (monitored as fluorescence generation) is illustrated in Fig. 1 , A -C. Treatment with MNU did not induce intracellular oxidation of DCFH in RGC-5 retinal ganglion cells (Fig. 1: B and E) . In contrast, in 661W photoreceptor-derived cells, intracellular radicals were significantly generated by treatment with MNU at 100, 500, and 1000 μg/mL or with H 2 O 2 at 1 mM compared with the controls (Fig. 1D) . Edaravone at 1 -20 μM scavenged radicals in a concentration-dependent manner ( Fig. 1: C and F) . Treatment with edaravone alone did not show any effects of ROS production in 661W cells without MNU (data not shown).
Immunocytochemical identification of rod photoreceptors and retinal cell death induced by MNU in primary retinal cells
To identify MNU-induced photoreceptor degeneration, we used primary dissociated retinal cultures from P8 mice. Immunostaining with antibodies against retinal cell-type markers was used to characterize the cell types in the retinal cultures. Representative photomicrographs of Hoechst 33342, rhodopsin, and GFAP stainings are shown in Fig. 2A . Figure 2A (a -d) and 2B show that the cultures contained rod photoreceptors at a proportion of 62.5%, and the rest were Müller glia, which showed GFAP positivity. We also performed rhodopsin and GFAP immunostaining after MNU treatment. Treatment with MNU at 100 μg/mL reduced the proportion of rod photoreceptors but increased that of Müller glia ( . To investigate whether MNU induces primary retinal cell death, we examined the change in absorbance (at 450 nm) that followed the cellular reduction of WST-8 to formazan. Treatment with MNU at 10 and 100 μg/mL significantly reduced cell viability. Edaravone at 10 μM inhibited cell death (Fig. 2C) .
Intracellular oxidation of DCFH induced by MNU in primary retinal cells
We investigated the radical-generating capacity of MNU in whole primary retinal cultures and individual cells. The kinetics of ROS reactivity (monitored as fluorescence generation) are illustrated in Fig. 3, A and B . Intracellular radicals were significantly generated by treatment with MNU at 100 to 1000 μg/mL compared with the control (Fig. 3C) . Edaravone at 0.1, 1, and 10 μM scavenged the radicals in a concentration-dependent manner (Fig. 3: B and D) . We also evaluated MNU-induced intracellular radical generation in individual cells by fluorescence microscopy. Representative photomicrographs of Hoechst 33342 staining and DCF fluorescence are shown in Fig. 3E . Untreated control cells displayed low-intensity fluorescence (Fig. 3Ea) . Treatment with 100 μg/mL MNU resulted in an increase in ROS production, as shown by the increased number of cells exhibiting DCF fluorescence (Fig. 3: Eb and F) . Edaravone at 10 μM reduced the number of ROS-generating cells induced by MNU (Fig. 
3: Ec and F).
Retinal damage induced by i.p. injection of MNU
In the histological evaluation, representative retinal images were taken at 7 days after MNU injection (Fig.  4) . No histological differences were apparent following the i.p. injection of 45 mg/kg MNU. MNU at 60 and 75 mg/kg decreased ONL thickness (vs. the untreated retina) drastically in a dose-dependent manner (Fig. 4: A and B) . (vs. the untreated retina). Edaravone at 1 mg/kg, i.v. but not at 0.3 mg/kg, i.v. significantly suppressed the reduction in ONL thickness (as compared with the vehicle) induced by MNU (60 mg/kg, i.p.; Fig. 4: C and D) . There was no effect of the administration of edaravone alone on retinal histology (data not shown).
MNU-induced increase in the number of TUNEL-positive cells
Fluorescein-labeled TUNEL staining revealed subtle intrinsic fluorescence in all retinal sections. TUNELpositive cells were observed in some parts of the ONL at 36, 48, and 72 h after the i.p. injection of 60 mg/kg MNU, but very few TUNEL-positive cells were detected in the untreated mice or at 12 and 24 h after MNU treatment (Fig. 5A) .
We evaluated the effect of edaravone by measurement of TUNEL-positive cell density at 36 h after injection of 60 mg/kg MNU (Fig. 5: B and C) . Almost no fluoresceinlabeled TUNEL cells were detected in normal retinal sections. Substantial fluorescence intensity was observed in vehicle-treated retinas. Edaravone (1 mg/kg, i.v.) significantly reduced the fluorescence intensity of TUNELpositive cells (vs. the vehicle-treated retina) (Fig. 5C ).
MNU-induced expressions of 8-OHdG and 4-HNE
Positive reactions for the oxidative stress biomarker 8-OHdG were observed in the ONL, beginning at 12 h after the i.p. injection of 60 mg/kg MNU, but almost none were seen in the normal retina (Fig. 6A) . Edaravone at 1 mg/kg, i.v. significantly reduced the number of 8-OHdG-positive cells induced by MNU treatment (vs. the vehicle-treated retina, Fig. 6B ).
For the second biomarker, 4-HNE, immunostaining was observed in photoreceptors, beginning at 12 h after the i.p. injection of 60 mg/kg MNU, but almost no staining was seen in the untreated retina (Fig. 6C) . Edaravone at 1 mg/kg, i.v. significantly reduced the expression of 4-HNE (vs. the vehicle-treated retina, Fig. 6D ).
Discussion
In the present study, MNU induced the generation of oxidative radicals in 661W photoreceptor cells, but not in RGC-5 cells. Edaravone treatment of 661W cells resulted in the scavenging of MNU-induced radicals. We also investigated the effects of MNU and edaravone in mouse primary retinal cultures. Primary retinal cells were isolated from postnatal day (P) 8 mice. Mouse retinal development is initiated at approximately embryonic day (E) 12 and involves proliferation, migration, and differentiation of neuronal precursor cells, a process that continues through final neuronal differentiation and maturation of neuronal synapses at approximately P8 (24) . Therefore, we hypothesize that the primary retinal cultures represent the in vivo situation in the adult mouse retina. We confirmed that the primary retinal cultures contained 62.5% rod photoreceptors, and the rest were Müller glia. Moreover, MNU induced ROS production and decreased the number of rod photoreceptors. ROS production was observed in 53% of the cells, as shown in Fig. 3F . This value was similar to the proportion of rod photoreceptors. Therefore, MNU may induce ROS production at least in rod photoreceptor cells. Furthermore, treatment with MNU did not induce intracellular oxidation in the mouse RGC-5 retinal ganglion cell line. Hence, MNU-induced ROS production may be cell specific. The number of Müller glial cells was not affected by MNU treatment; therefore, Müller glia is not likely to be involved in cell death. This study is the first to report that MNU elevates ROS in rod and cone photoreceptor cells and induces photoreceptor cell death in vitro. Edaravone may inhibit MNU-induced photoreceptor cell degeneration by its ROS-scavenging activity.
An extensive investigation in animals has revealed that MNU-induced photoreceptor cell loss is due to apoptosis with a decrease in Bcl-2 protein, increase in Bax protein, and nuclear factor κB and activation of caspases (1, 5) . Previous studies have evaluated a caspase-3 inhibitor (1), nicotinamide (25) , X-linked inhibitor of apoptosis protein (26) , poly(ADP-ribose) polymerase inhibitor (27) , and mutant of acidic fibroblast growth factor (28) as possible therapies for MNU-induced cell loss because they were found to prevent MNU-induced retinal damage and counteract photoreceptor cell loss. Oxidative stress caused by ROS induces the activation of the Bcl-2 family member proteins Bax/Bak, the opening of permeability transition pores, the disruption of the mitochondrial membrane potential, the release of cytochrome c, the activation of caspases, and cell death. Thus, the production of ROS by rod and cone photoreceptor cells might affect MNU-induced retinal degeneration in mice. Considering the specificity of MNU-induced retinal damage and its alkylation activity, MNU may induce the ROS production via protein alkylation, especially photoreceptor specific proteins such as rhodopsin, opsin, transducing, and allestin.
When supplied in vivo in mice, MNU at 60 and 75 mg/ kg drastically decreased ONL thickness in a dose-dependent manner. In a previous study, a drastic decrease in ONL thickness was noticed at 7 days after MNU treatment, but the ganglion cell layer, inner plexiform layer, and INL were well preserved (29) . However, in the present study, MNU at 75 mg/kg slightly decreased the thickness of the INL. This result shows that MNU at high doses may affect various retinal cell layers by mechanisms other than oxidative stress, such as an excessive alkylation.
Edaravone protected against MNU-induced retinal cell degradation and decreased the number of cells showing positive TUNEL staining, which is a marker of DNA fragmentation. In our previous study, edaravone was found to prevent both retinal ganglion cell loss and TUNEL expression in retinal cells induced by intravitreally injected NMDA (18) . In an in vitro study using retinal ganglion cells, edaravone showed stronger scavenging activity against the intracellular ·OH radical than the other examined radicals, O 2 · − and H 2 O 2 , whereas Trolox, a water-soluble vitamin E analogue, showed stronger scavenging activity against O 2 · − and H 2 O 2 than the ·OH radical (18) .
Edaravone also reduced the MNU-induced expressions of 8-OHdG and 4-HNE in the murine retinas. One of the major products of DNA damage induced by ROS is 8-OHdG, the level of which is a useful marker of oxidative damage due to aging, cancer, and other degenerative diseases (30 -32) . A second major compound, the aldehyde 4-HNE, is generated by a free-radical attack on ω-6 polyunsaturated fatty acids and is largely responsible for pathogenesis during oxidative stress (33, 34) . The chemical nature of 4-HNE makes it highly reactive towards the free sulfhydryl groups of proteins, resulting in the formation of thioether adducts that undergo further cyclization to form hemiacetals (35) . Both of these biomarkers are therefore closely related to oxidative stress. Hence, edaravone would be expected to exert neuroprotective effects against retinal photoreceptor degradation induced by oxidative stress, most probably by scavenging the ·OH radicals. The prevalence of typical retinitis pigmentosa is reported to be approximately 1 in 4000, and no effective treatment yet exists. Retinitis pigmentosa originates from 1 of hundreds of mutations that result in a gene product that can damage the rods or from homozygous mutations that cause deficiency of a protein indispensable for rod survival. The death of rods is inevitably followed by cone cell death, caused mainly by oxidative damage (36, 37) . Usui et al. reported that generation of excessive ROS caused oxidative damage to cones in the retinal degeneration-1 (rd1+/+) mouse, a model of retinitis pigmentosa (38) . A mixture of antioxidants, including α-tocopherol, ascorbic acid, Mn (III) tetrakis (4-benzoic acid) porphyrin, and α-lipoic acid, reduced cone cell death in these rd1+/+ mice (36) . Although the apoptosis cascade induced by MNU may differ from that in human retinitis pigmentosa, the present data indicate that MNU-induced retinal degeneration has features common to retinitis pigmentosa in that the degeneration is specific to photoreceptor cells and involves oxidative stress.
In conclusion, we have demonstrated that MNU induces the generation of oxidative radicals and cell death specifically in retinal photoreceptor cells. In addition, systemic administration of edaravone, a free radical scavenger, inhibits retinal degeneration induced by MNU. These findings indicate that oxidative stress plays a pivotal role in MNU-induced retinal photoreceptor degradation. Although the mechanism of pathogenesis of MNU-induced photoreceptor cell damage differs from that of human retinitis pigmentosa, the results of our study may help us to understand the pathogenesis of retinitis pigmentosa.
